Homocysteine is an independent risk factor for various cardiovascular diseases. There are two ways to remove homocysteine from embryonic cardiac cells： remethylation to form methionine or ...transsolfuration to form cysteine. Cystathionine β-synthase （CBS） catalyzes the first step of homocysteine transsulfuration as a rate-limiting enzyme. In this study, we identified a functional variant -4673C〉G （rs2850144） in the CBS gene promoter region that significant- ly reduces the susceptibility to congenital heart disease （CHD） in a Han Chinese population consisting of 2 340 CHD patients and 2 270 controls. Individuals carrying the heterozygous CG and homozygous GG genotypes had a 15% （odds ratio （OR） = 0.85, 95% confidence interval （CI） = 0.75-0.96, P = 0.011） and 40% （OR = 0.60, 95% CI = 0.49-0.73, P = 1.78 ×10^-7） reduced risk to develop CHD than the wild-type CC genotype carriers in the combined samples, respec-tively. Additional stratified analyses demonstrated that CBS -4673C〉G is significantly related to septation defects and conotruncal defects. In vivo detection of CBS mRNA levels in human cardiac tissues and in vitro luciferase assays consistently showed that the minor G allele significantly increased CBS transcription. A functional analysis revealed that both the attenuated transcription suppressor SP1 binding affinity and the CBS promoter hypomethylation spe-cifically linked with the minor G allele contributed to the remarkably upregulated CBS expression. Consequently, the carriers with genetically increased CBS expression would benefit from the protection due to the low homocysteine levels maintained by CBS in certain cells during the critical heart development stages. These results shed light on un-expected role of CBS and highlight the importance of homocysteine removal in cardiac development.
Full text
Available for:
EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
PDF